NCT02128906 2025-03-26
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
Phase 2 Recruiting
University of Pittsburgh
University of Kentucky
Arbeitsgemeinschaft medikamentoese Tumortherapie